1. Home
  2. FLIC vs DMAC Comparison

FLIC vs DMAC Comparison

Compare FLIC & DMAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FLIC
  • DMAC
  • Stock Information
  • Founded
  • FLIC 1927
  • DMAC 2000
  • Country
  • FLIC United States
  • DMAC United States
  • Employees
  • FLIC N/A
  • DMAC N/A
  • Industry
  • FLIC Major Banks
  • DMAC Biotechnology: Pharmaceutical Preparations
  • Sector
  • FLIC Finance
  • DMAC Health Care
  • Exchange
  • FLIC Nasdaq
  • DMAC Nasdaq
  • Market Cap
  • FLIC 275.5M
  • DMAC 267.7M
  • IPO Year
  • FLIC N/A
  • DMAC N/A
  • Fundamental
  • Price
  • FLIC $12.96
  • DMAC $6.51
  • Analyst Decision
  • FLIC Hold
  • DMAC Strong Buy
  • Analyst Count
  • FLIC 1
  • DMAC 3
  • Target Price
  • FLIC $13.00
  • DMAC $7.00
  • AVG Volume (30 Days)
  • FLIC 99.6K
  • DMAC 81.8K
  • Earning Date
  • FLIC 01-30-2025
  • DMAC 03-18-2025
  • Dividend Yield
  • FLIC 6.48%
  • DMAC N/A
  • EPS Growth
  • FLIC N/A
  • DMAC N/A
  • EPS
  • FLIC 0.75
  • DMAC N/A
  • Revenue
  • FLIC $84,928,000.00
  • DMAC N/A
  • Revenue This Year
  • FLIC N/A
  • DMAC N/A
  • Revenue Next Year
  • FLIC N/A
  • DMAC N/A
  • P/E Ratio
  • FLIC $17.28
  • DMAC N/A
  • Revenue Growth
  • FLIC N/A
  • DMAC N/A
  • 52 Week Low
  • FLIC $9.30
  • DMAC $2.14
  • 52 Week High
  • FLIC $15.03
  • DMAC $6.82
  • Technical
  • Relative Strength Index (RSI)
  • FLIC 47.48
  • DMAC 62.22
  • Support Level
  • FLIC $13.57
  • DMAC $5.75
  • Resistance Level
  • FLIC $14.00
  • DMAC $6.82
  • Average True Range (ATR)
  • FLIC 0.47
  • DMAC 0.30
  • MACD
  • FLIC -0.05
  • DMAC 0.02
  • Stochastic Oscillator
  • FLIC 32.04
  • DMAC 74.48

About FLIC First of Long Island Corporation (The)

First of Long Island Corp is a holding company that provides financial services. It offers services of saving accounts, current accounts, and capital gain accounts. The company also provides lending services, such as commercial and residential mortgage loans, industrial loans, small business credit scored loans, and other credit facilities. In addition, the company provides account reconciliation services, ATM Banking, bill payment, cash management services, mobile banking, online banking, and payroll services to privately owned businesses, professionals, consumers, and public bodies. Revenue earned by the company mainly consists of the interest on loans and investment securities, fees on deposit accounts, and income from investment management.

About DMAC DiaMedica Therapeutics Inc.

DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is principally engaged in the business activity of developing treatments for unmet clinical needs or where no therapies are available with a primary focus on chronic kidney disease and acute ischemicstroke. Its pipeline product DM199 is a recombinant form of human tissue kallikrein-1.

Share on Social Networks: